Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.
Condition(s):Disorder Related to Renal TransplantationLast Updated:February 25, 2014Completed
Hide Studies Not Open or Pending
Condition(s):Disorder Related to Renal TransplantationLast Updated:February 25, 2014Completed
Condition(s):Kidney TransplantationLast Updated:June 2, 2017Unknown status
Condition(s):SclerodermaLast Updated:July 18, 2018Withdrawn
Condition(s):Kidney Transplantation; ImmunosuppressionLast Updated:May 13, 2020Unknown status
Condition(s):Atopic DermatitisLast Updated:December 16, 2021Completed
Condition(s):Kidney TransplantationLast Updated:June 19, 2012Completed
Condition(s):Disorder Related to Renal TransplantationLast Updated:June 9, 2014Completed
Condition(s):Hemorrhagic Hereditary Telangiectasia (HHT)Last Updated:July 1, 2020Completed
Condition(s):VitiligoLast Updated:October 10, 2012Unknown status
Condition(s):Atopic DermatitisLast Updated:July 31, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.